ERBB2 and acute lymphoblastic leukemia: We document caspase-dependent cell death in patient derived Ph+ALL lines after treatment with ErbB TKIs alone and in combination with BCR/ABL-directed TKI, providing impetus for the clinical testing of this strategy for ErbB2-expressing Ph+ALL.